Overview

The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine

Status:
Completed
Trial end date:
2019-04-03
Target enrollment:
Participant gender:
Summary
This is a Phase 4, randomized, double-blind, placebo-controlled study to evaluate the potential for clinical dependence and withdrawal symptoms associated with valbenazine.
Phase:
Phase 4
Details
Lead Sponsor:
Neurocrine Biosciences
Treatments:
Tetrabenazine